WHO urges âimmediateâ action on falsified medicines
The WHO called on stakeholders in various nations to take âimmediate and coordinated actionâ to shield children from using contaminated cough syrups following.
Drugs
Pharma
Drugs
Pharma
Merck says it has identified the cause of contamination of its diabetes medicines
Merck says its diabetes drugs got contaminated during storage and manufacturings and it will improve the same to prevent it in future
Health
Pharma
High global food prices leave less food on plates of Latin America, Caribbean
More than 131 million people in the Latin American and Caribbean population are not able to afford a healthy diet, due to high.
Drugs
Pharma
Johnson & Johnson pulls out of HIV phase III trial
Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.
Drugs
Pharma
India bolsters regulators to brace global competition
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister.
Drugs
Pharma
Glenmark’s heart failure treatment drug makes India debut
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs
Pharma
US regulatory nod for Lupinâs HIV drug in the works
Pharma major Lupin has received a âtentative approvalâ, from the United States Food and Drug Administration (FDA), to market medicines used to treat.
Drugs
Pharma
USFDA grants âtentative approvalâ to Zydusâ mental health drug
The USFDA has granted Zydus Lifesciences Limited âtentative approvalâ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Health
Pharma
Uncategorized
Domestic formulations to aid pharma growth: ICICI Direct
The Indian pharmaceutical industry is expected to witness âdecent growthâ during the three-month period through 31 March 2023, mainly led by continued traction.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in JapanïżŒ
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.